SCHEMBL30690683

SCHEMBL30690683

CCOC(=O)c1cnc(C)c(NC(=O)c2cnc3c(c2)cc(-c2cnn(C)c2)n3COCC[Si](C)(C)C)c1

nearest known ligand 0.39

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PDGFRA P16234 2/20 0.39
CHRM1 P11229 1/20 0.39
HRH3 Q9Y5N1 1/20 0.39
CSF1R P07333 1/20 0.37
KIT P10721 1/20 0.37
WNT1 P04628 6/20 0.34
DYRK1A Q13627 6/20 0.34
GSK3B P49841 3/20 0.34
CLK2 P49760 2/20 0.34
CLK3 P49761 2/20 0.34
CA12 O43570 2/20 0.34
CA1 P00915 2/20 0.34
CA2 P00918 2/20 0.34
CA5A P35218 2/20 0.34
CA9 Q16790 2/20 0.34
ABL1 P00519 1/20 0.34
HDAC3 O15379 2/20 0.33
HDAC1 Q13547 2/20 0.33
HDAC2 Q92769 2/20 0.33
POLB P06746 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL30690679 0.92 PDGFRA (0.40) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690781 0.89 PDGFRA (0.39) PDGFRACHRM1HRH3CSF1RKIT
Hydrochloric Acid SCHEMBL30690806 0.89 PDGFRA (0.38) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690760 0.86 CSF1R (0.40) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690685 0.85 PDGFRA (0.42) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690642 0.85 CSF1R (0.41) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690812 0.84 PDGFRA (0.60) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690774 0.83 GSK3B (0.41) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690658 0.83 CSF1R (0.40) PDGFRACHRM1HRH3CSF1RKIT
SCHEMBL30690764 0.80 CHEK1 (0.39) WNT1DYRK1AGSK3BCLK2CLK3

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2023247593-A1 PYRROLOPYRIDINE CARBOXAMIDES AND THEIR USES AS PDGFR INHIBITORS ACTELION PHARMACEUTICALS LTD (CH) 2023-12-28 WO disclosed